da Vinci Surgical System Timeline

Intuitive Surgical launched da Vinci 5 in 2024, the most significant generational upgrade since the Xi in 2014. Key additions include haptic force feedback — a feature that had been absent from all previous da Vinci generations — and a computing platform described by Intuitive as having 10,000 times more processing power than the Xi. Force feedback allows surgeons to feel the resistance of tissue through the instrument, which prior generations could not provide. The system also introduced improved instrument design and an updated surgeon console interface.

The da Vinci Xi redesigned the patient-side cart with overhead boom-mounted arms rather than the column-based architecture of the Si. The boom architecture allowed the arms to be repositioned more freely around the patient and gave surgeons better access across a wider range of anatomical targets without needing to move the entire cart. The Xi also introduced a new endoscope that could dock to any arm — a change that improved surgical flexibility for complex multi-quadrant procedures.

The da Vinci Si introduced a dual-console configuration in which two surgeons could operate simultaneously — one as the primary surgeon, one as an assistant or trainee. This made it possible for an experienced surgeon to supervise and take over from a trainee during a procedure. The dual console became a key selling point for academic medical centres and teaching hospitals, where residents needed to develop robotic surgery skills under supervision. The Si also improved the 3D visualisation system and refined the instrument design.

The da Vinci S was the second major generation of the platform, introducing improved EndoWrist instrument design, better high-definition image quality, and a more ergonomic surgeon console. The S also added a third-arm instrument port (bringing the total to four arms including the camera arm), giving surgeons a dedicated assistant arm during procedures. The generation was significant in expanding the range of procedures for which the system was used beyond urology into broader general and gynaecological surgery.

The first completely robot-assisted coronary artery bypass surgery was performed at the Leipzig Heart Centre using the da Vinci system. The procedure demonstrated that robotic assistance could enable surgery in anatomical locations where conventional laparoscopic instruments could not reach. The Leipzig procedure attracted significant clinical attention as an early demonstration of what minimally invasive robotic surgery could achieve in cardiac applications.

The US Food and Drug Administration cleared the da Vinci Surgical System in 2000, initially for laparoscopic surgical procedures. FDA clearance opened the US hospital market, which would become the largest single market for the system over the following two decades. Within a few years, the system received clearance for additional indications including prostatectomy — a procedure that would become its highest-volume application in the US.

The original da Vinci Surgical System received CE marking in Europe in 1999 and became commercially available to European hospitals. Intuitive Surgical was founded in 1995 with technology licensed from SRI International and the Stanford Research Institute, building on research originally funded by DARPA with the aim of enabling telesurgery for battlefield injuries. The commercial system that emerged was designed for hospitals, not field conditions, but the minimally invasive approach — small incisions, rapid recovery — proved to have broad clinical utility.